Evommune, Inc. (EVMN) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -27.5M | -16.7M | -9.63M | -26.21M | -23.9M | -22.37M |
| Operating CF Margin % | - | - | -96.35% | - | -796.63% | - |
| Operating CF Growth % | -15.08% | 25.35% | - | - | - | - |
| Net Income | -21.67M | -28.27M | -12.47M | -13.56M | -14.56M | -18.32M |
| Depreciation & Amortization | 349K | 326K | 311K | 375K | 377K | 345.5K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 448K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.66M | 3.61M | 49K | -8.74M | 244K | -5.15M |
| Working Capital Changes | -8.84M | 7.64M | 2.48M | -4.27M | -9.96M | 308K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -3.75M | 3.85M | -97K | -3.9M | -691K | 2.85M |
| Cash from Investing | -85.36M | -122.9M | -23.91M | 18M | 13.5M | -11.83M |
| Capital Expenditures | -83K | -104K | -131K | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | 1.31% | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | -11.83M |
| Cash from Financing | 117.11M | 156.85M | -274K | 64.34M | -152K | 24.79M |
| Debt Issued (Net) | -87K | 72K | -445K | -155K | 0 | 0 |
| Equity Issued (Net) | 117.2M | 158M | -874K | 65.23M | 2K | 49.84M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -1.22M | 1.04M | -736K | -154K | 24.79M |
| Net Change in Cash | 4.25M | 17.25M | -35.02M | 56.13M | 5.7M | -1.89M |
| Free Cash Flow | -27.59M | -16.8M | -9.77M | -26.21M | -23.9M | -22.37M |
| FCF Margin % | - | - | -97.66% | - | -796.63% | - |
| FCF Growth % | -15.43% | 24.88% | - | - | - | - |
| FCF per Share | -0.82 | -0.53 | -0.31 | -0.87 | -0.79 | -0.74 |
| FCF Conversion (FCF/Net Income) | 1.27x | 0.59x | 0.77x | 1.93x | 1.64x | 1.22x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 7K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 |